Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Sprout Health vs GetRelief Rx

Two GLP-1 desks, one scoreboard. We put Sprout Health and GetRelief Rx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 6 · Grade B

Sprout Health

Visit Sprout Health Full brief →
vs
No. 371 · Grade C

GetRelief Rx

Visit GetRelief Rx Full brief →

The verdict

Sprout Health takes this head-to-head.

Sprout Health scores 86 to 57 on our six-factor Brief Score — A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

That doesn't make GetRelief Rx a bad call — it's best for readers who want sublingual (non-injectable) compounded glp-1 drops for the needle-averse. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
90
36
Supply Reliability
82
54
Transparency
88
72
Access Breadth
92
62
Clinical Oversight
78
71
Track Record
84
53
Sprout HealthBrief Score 86 · 57GetRelief Rx

Price, coverage & the tracker

Sprout HealthGetRelief Rx
Brief Score86/100 (B)57/100 (C)
Semaglutide$149/moFrom $269/mo (compounded oral)
Tirzepatide$199/moFrom $179/mo (compounded oral)
CoverageNot disclosedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

Sprout Health: Compounded $149 semaglutide / $199 tirzepatide held flat this cycle, with a brand-name Wegovy/Zepbound path available on the same account.

GetRelief Rx: New to the tracker on 1 August 2026. The published line reads From $179/mo (compounded oral) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.